Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001510015 | SCV001716940 | benign | Pyruvate dehydrogenase E2 deficiency | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001510015 | SCV001876767 | benign | Pyruvate dehydrogenase E2 deficiency | 2021-07-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000676209 | SCV001946923 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 30389748) |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000116878 | SCV002051449 | likely benign | not specified | 2021-12-03 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000676209 | SCV005219597 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genetic Services Laboratory, |
RCV000116878 | SCV000150963 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. | |
Mayo Clinic Laboratories, |
RCV000676209 | SCV000801962 | benign | not provided | 2016-02-15 | no assertion criteria provided | clinical testing |